Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Diabetologia|August 27, 2021
Genetic variation at ERBB3/IKZF4 and sexual dimorphism in epitope spreading in single autoantibody-positive relativesJulie Vandewalle, Bart J Van der Auwera, Henna Amin, et al.
The Journal of Clinical Endocrinology and Metabolism|September 17, 2021
Relationship Between Time in Range, Glycemic Variability, HbA1c, and Complications in Adults With Type 1 Diabetes MellitusAnass El Malahi, Michiel Van Elsen, Sara Charleer, et al.
Heliyon|April 8, 2025
The stage- and subgroup-specific impact of non-HLA polymorphisms on preclinical type 1 diabetes progressionJulie Vandewalle, Aster K Desouter, Bart J Van der Auwera, et al.
Transplantation|May 21, 2020
Use of Culture to Reach Metabolically Adequate Beta-cell Dose by Combining Donor Islet Cell Isolates for Transplantation in Type 1 Diabetes PatientsDaHae Lee, Pieter Gillard, Robert Hilbrands, et al.
Transplantation|October 26, 2016
Age and Early Graft Function Relate With Risk-Benefit Ratio of Allogenic Islet Transplantation Under Antithymocyte Globulin-Mycophenolate Mofetil-Tacrolimus Immune SuppressionDaHae Lee, Bart Keymeulen, Robert Hilbrands, et al.
Diabetes Care|April 30, 2002
The incidence of type 1 diabetes in the age group 0-39 years has not increased in Antwerp (Belgium) between 1989 and 2000: evidence for earlier disease manifestationIlse Weets, Ivo H De Leeuw, Marc V L Du Caju, et al.
Nature Biotechnology|November 27, 2023
Encapsulated stem cell-derived β cells exert glucose control in patients with type 1 diabetesBart Keymeulen, Kaat De Groot, Daniel Jacobs-Tulleneers-Thevissen, et al.
Diabetes, Obesity & Metabolism|May 19, 2022
Ladarixin, an inhibitor of the interleukin-8 receptors CXCR1 and CXCR2, in new-onset type 1 diabetes: A multicentre, randomized, double-blind, placebo-controlled trialLorenzo Piemonti, Bart Keymeulen, Pieter Gillard, et al.
Diabetes Care|March 17, 2018
Accelerated Progression to Type 1 Diabetes in the Presence of <i>HLA-A*24</i> and <i>-B*18</i> Is Restricted to Multiple Islet Autoantibody-Positive Individuals With Distinct <i>HLA-DQ</i> and Autoantibody Risk ProfilesElse M Balke, Eric V Balti, Bart Van der Auwera, et al.
Diabetologia|January 18, 2024
Cost-utility analysis of Dexcom G6 real-time continuous glucose monitoring versus FreeStyle Libre 1 intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in BelgiumMargaretha M Visser, Astrid Van Muylder, Sara Charleer, et al.
Pageof 10